ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628665 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628665; 2) Community: the network communities that were significantly associated with the response to NSC 628665; 3) Molecule: the relationships between components within communities and NSC 628665; 4) MDR: the compounds that were significantly associated with the NSC 628665.

NSC Compound Enrichment Correlation
NSC 693248 Null 0.0434721470609156 0.19730092
NSC 694509 Null 0.0434721470609156 0.29839399
NSC 694619 Null 0.0434721470609156 0.36022919
NSC 715407 Null 0.0434721470609156 0.1214722
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.097648116
NSC 725098 Null 0.0434721470609156 0.29467837
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0434721470609156 0.18401157
NSC 726217 Combretastatin A4-analogue 0.0434721470609156 0.14455842
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0434721470609156 0.51563322
NSC 740357 Null 0.0434721470609156 -0.10541585
Total:109  Current:86    [First] [Prev] [Next] [Last]